Predicting translational progress in biomedical research

Fundamental scientific advances can take decades to translate into improvements in human health. Shortening this interval would increase the rate at which scientific discoveries lead to successful treatment of human disease. One way to accomplish this would be to identify which advances in knowledge...

Full description

Saved in:
Bibliographic Details
Published inPLoS biology Vol. 17; no. 10; p. e3000416
Main Authors Hutchins, B. Ian, Davis, Matthew T., Meseroll, Rebecca A., Santangelo, George M.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 10.10.2019
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fundamental scientific advances can take decades to translate into improvements in human health. Shortening this interval would increase the rate at which scientific discoveries lead to successful treatment of human disease. One way to accomplish this would be to identify which advances in knowledge are most likely to translate into clinical research. Toward that end, we built a machine learning system that detects whether a paper is likely to be cited by a future clinical trial or guideline. Despite the noisiness of citation dynamics, as little as 2 years of postpublication data yield accurate predictions about a paper's eventual citation by a clinical article (accuracy = 84%, F1 score = 0.56; compared to 19% accuracy by chance). We found that distinct knowledge flow trajectories are linked to papers that either succeed or fail to influence clinical research. Translational progress in biomedicine can therefore be assessed and predicted in real time based on information conveyed by the scientific community's early reaction to a paper.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Since the authors work in the Division of Program Coordination, Planning, and Strategic Initiatives at the National Institutes of Health, our work could have policy implications for how research portfolios are evaluated.
ISSN:1545-7885
1544-9173
1545-7885
DOI:10.1371/journal.pbio.3000416